Alector (ALEC) Cash & Equivalents (2018 - 2026)
Alector (ALEC) reported Cash & Equivalents of $77.0 million for Q1 2026, up 102.68% year-over-year from $38.0 million in Q1 2025, and up 16.96% quarter-over-quarter from $65.8 million in Q4 2025.
Alector (ALEC) Cash & Equivalents (2018 - 2026) Analysis & Trends
Alector (ALEC) has 9 years of Cash & Equivalents data on file, last reported at $77.0 million in Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $77.0 million, up 102.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $77.0 million (up 102.68% YoY), and the FY2025 annual result was $65.8 million, up 99.27% from the prior year.
- Cash & Equivalents improved to $77.0 million in Q1 2026 per ALEC's latest filing, from $65.8 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $454.6 million in Q1 2022 and troughed at $33.0 million in Q4 2024.
- A 5-year average of $115.4 million and a median of $76.5 million in 2025 frame the typical range for Cash & Equivalents.
- On a YoY basis, Cash & Equivalents climbed as much as 310.67% in 2022 and fell as far as 64.33% in 2022.
- A 5-year view of Cash & Equivalents shows it stood at $154.3 million in 2022, then slumped by 51.69% to $74.6 million in 2023, then sank by 55.71% to $33.0 million in 2024, then soared by 99.27% to $65.8 million in 2025, then advanced by 16.96% to $77.0 million in 2026.
- Business Quant data shows ALEC's Cash & Equivalents at $77.0 million in Q1 2026, $65.8 million in Q4 2025, and $76.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | Alector | 193.53 Mn | -12.98 Mn | - | 76.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.96 Mn |
| Dec 31, 2025 | 65.80 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 44.77 Mn |
| Mar 31, 2025 | 37.97 Mn |
| Dec 31, 2024 | 33.02 Mn |
| Sep 30, 2024 | 37.16 Mn |
| Jun 30, 2024 | 47.55 Mn |
| Mar 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 74.56 Mn |
| Sep 30, 2023 | 101.96 Mn |
| Jun 30, 2023 | 131.54 Mn |
| Mar 31, 2023 | 195.56 Mn |
| Dec 31, 2022 | 154.32 Mn |
| Sep 30, 2022 | 184.23 Mn |
| Jun 30, 2022 | 172.27 Mn |
| Mar 31, 2022 | 454.62 Mn |
| Dec 31, 2021 | 329.15 Mn |
| Sep 30, 2021 | 516.53 Mn |
| Jun 30, 2021 | 125.71 Mn |